- Home
- GTIM vs LPCN Comparison
GTIM vs LPCN Comparison
Compare GTIM & LPCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GTIM
- LPCN
- Stock Information
- Founded
- GTIM 1987
- LPCN 1997
- Country
- GTIM United States
- LPCN United States
- Employees
- GTIM 2110
- LPCN N/A
- Industry
- GTIM Restaurants
- LPCN Biotechnology: Pharmaceutical Preparations
- Sector
- GTIM Consumer Discretionary
- LPCN Health Care
- Exchange
- GTIM Nasdaq
- LPCN Nasdaq
- Market Cap
- GTIM 17.1M
- LPCN 16.1M
- IPO Year
- GTIM 1990
- LPCN N/A
- Fundamental
- Price
- GTIM $1.64
- LPCN $3.17
- Analyst Decision
- GTIM
- LPCN Strong Buy
- Analyst Count
- GTIM 0
- LPCN 2
- Target Price
- GTIM N/A
- LPCN $9.00
- AVG Volume (30 Days)
- GTIM 18.1K
- LPCN 71.7K
- Earning Date
- GTIM 07-31-2025
- LPCN 05-08-2025
- Dividend Yield
- GTIM N/A
- LPCN N/A
- EPS Growth
- GTIM 65.30
- LPCN N/A
- EPS
- GTIM 0.09
- LPCN N/A
- Revenue
- GTIM $144,322,000.00
- LPCN $3,674,834.00
- Revenue This Year
- GTIM N/A
- LPCN N/A
- Revenue Next Year
- GTIM N/A
- LPCN N/A
- P/E Ratio
- GTIM $17.56
- LPCN N/A
- Revenue Growth
- GTIM 4.14
- LPCN N/A
- 52 Week Low
- GTIM $1.51
- LPCN $2.68
- 52 Week High
- GTIM $3.45
- LPCN $11.79
- Technical
- Relative Strength Index (RSI)
- GTIM 42.55
- LPCN 43.78
- Support Level
- GTIM $1.56
- LPCN $3.00
- Resistance Level
- GTIM $1.72
- LPCN $3.49
- Average True Range (ATR)
- GTIM 0.08
- LPCN 0.34
- MACD
- GTIM 0.02
- LPCN -0.05
- Stochastic Oscillator
- GTIM 61.90
- LPCN 16.50
About GTIM Good Times Restaurants Inc.
Good Times Restaurants Inc is engaged in developing, owning, operating, and franchising hamburger-oriented drive-through restaurants. It operates through two segments: Good Times Burgers and Frozen Custard restaurants which operate in the quick-service drive-through dining industry; and Bad Daddy's Burger Bar restaurants which operate in the full-service upscale casual dining industry. The company generates maximum revenue from the Bad Daddy's Burger Bar restaurants segment. Its menu categories include burgers; chicken; frozen custard; slides and drinks.
About LPCN Lipocine Inc.
Lipocine Inc is a clinical-stage biopharmaceutical company, that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP'RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.